Cognitive Functions Associated with Brain Imaging Markers in Patients with Psoriasis

Psoriasis is a severe inflammatory disease associated with a higher comorbidity of depression, cognitive dysfunction and brain atrophy. The association between psoriasis, magnetic resonance imaging (MRI) markers and cognitive impairment has rarely been investigated, and the existing results are conflicting. Methods. This study included 89 subjects (53 patients with psoriasis and 36 healthy controls). The severity of psoriasis was evaluated using the Psoriasis Area and Severity Index (PASI) score; for depression, the Hospital Anxiety and Depression Scale (HADS) scale was used. Neuropsychological tests were also applied, including a Trail Making Test (TMT) as well as Digit Span, Stroop, Verbal Fluency and Rey Auditory Verbal Learning tests. MRI scans were performed using a 1.5 T scanner. Brain volumetry, white matter lesions, grey matter and white matter were evaluated. The extent of these changes was assessed on the Fazekas scale. The differences between groups were evaluated using a Student’s t-test and a Mann-Whitney U test, and a Pearson correlation analysis was also performed. Results. Patients with psoriasis presented worse achievements on all the neuropsychological tests and showed more intense changes on MRI compared to healthy controls. The severity of psoriasis as determined by PASI scores was associated with depression, and a greater psychomotor slowness severity of changes in the brain was associated with poorer results on the neurological tests. Conclusions. Our results indicate the possibility of progressive brain atrophy related to cognitive decline in psoriasis.

[1]  L. Kuai,et al.  Association Between Psoriasis and Dementia: Current Evidence , 2020, Frontiers in Aging Neuroscience.

[2]  Drew D. Gourley,et al.  Cognition, Brain Structure, and Brain Function in Individuals with Obesity and Related Disorders , 2020, Current Obesity Reports.

[3]  C. Yeh,et al.  Major depressive disorder increased risk of psoriasis: A propensity score matched cohort study. , 2020, Journal of affective disorders.

[4]  K. Kridin,et al.  Psoriasis and Dementia: A Cross-sectional Study of 121,801 Patients , 2020, Acta dermato-venereologica.

[5]  A. Drucker,et al.  Association between psoriasis and risk of dementia: a systematic review and meta-analysis. , 2020, Journal of the American Academy of Dermatology.

[6]  H. Yen,et al.  Is psoriasis associated with dementia or cognitive impairment? A Critically Appraised Topic * , 2020, The British journal of dermatology.

[7]  F. Lira,et al.  Pathophysiological Features of Obesity and Its Impact on Cognition: Exercise Training as a Non-Pharmacological Approach. , 2020, Current pharmaceutical design.

[8]  Herng‐Ching Lin,et al.  Association Between Psoriasis and Dementia: A Population-Based Case–Control Study , 2019, American Journal of Clinical Dermatology.

[9]  B. Strober,et al.  Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. , 2019, Journal of the American Academy of Dermatology.

[10]  T. Beblo,et al.  Verstimmt, verzerrt, vergesslich: Das Zusammenwirken emotionaler und kognitiver Dysfunktionen bei Depression , 2019, neuropsychiatrie.

[11]  C. Chi,et al.  Association of Psoriasis With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis , 2018, JAMA dermatology.

[12]  R. McIntyre,et al.  Cognitive impairment in major depressive disorder , 2018, CNS Spectrums.

[13]  M. Vernooij,et al.  Psoriasis is not associated with cognition, brain imaging markers and risk of dementia: the Rotterdam Study. , 2018, Journal of American Academy of Dermatology.

[14]  B. Baune,et al.  The role of cognitive impairment in psychosocial functioning in remitted depression. , 2018, Journal of affective disorders.

[15]  D. Lester,et al.  Cognitive impairment in patients with psoriasis: A matched case-control study. , 2018, Journal of psychosomatic research.

[16]  A. Armstrong,et al.  Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[17]  K. Årestedt,et al.  Is the Hospital Anxiety and Depression Scale (HADS) a valid measure in a general population 65–80 years old? A psychometric evaluation study , 2017, Health and Quality of Life Outcomes.

[18]  S. Langan,et al.  Psoriasis and comorbid diseases: Epidemiology. , 2017, Journal of the American Academy of Dermatology.

[19]  M. Goldacre,et al.  Associations between specific autoimmune diseases and subsequent dementia: retrospective record-linkage cohort study, UK , 2017, Journal of Epidemiology & Community Health.

[20]  M. Haberka,et al.  Carotid intima-media thickness in patients with mild or moderate psoriasis , 2016, Postepy dermatologii i alergologii.

[21]  D. Keskin,et al.  Cognitive Impairment in Patients with Psoriasis: A Cross-Sectional Study Using the Montreal Cognitive Assessment , 2016, American Journal of Clinical Dermatology.

[22]  E. Samarasekera,et al.  Psoriasis: guidance on assessment and referral. , 2014, Clinical medicine (London).

[23]  A. Beltramello,et al.  Mild Cognitive Impairment in Patients with Moderate to Severe Chronic Plaque Psoriasis , 2014, Dermatology.

[24]  R. Warren,et al.  Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis. , 2013, The Journal of investigative dermatology.

[25]  D. Blacker,et al.  The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[26]  H. Völzke,et al.  Psoriasis is associated with increased intima-media thickness--the Study of Health in Pomerania (SHIP). , 2012, Atherosclerosis.

[27]  A. Armstrong,et al.  Coronary artery disease in patients with psoriasis referred for coronary angiography. , 2012, The American journal of cardiology.

[28]  H. Tse,et al.  Increased arterial stiffness in patients with psoriasis is associated with active systemic inflammation , 2011, The British journal of dermatology.

[29]  S. Chimenti,et al.  An Italian Study on Psoriasis and Depression , 2006, Dermatology.

[30]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[31]  S. González‐Parra,et al.  Psoriasis and Depression: The Role of Inflammation. , 2019, Actas dermo-sifiliograficas.